Cargando…

Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise

Detalles Bibliográficos
Autor principal:	Yoshida, Go J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499343/ https://www.ncbi.nlm.nih.gov/pubmed/30767335 http://dx.doi.org/10.1002/1348-9585.12015

Ejemplares similares

Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise
por: Zhang, Meibian, et al.
Publicado: (2019)

Emergency response to occupational brucellosis in a pharmaceutical manufacturing enterprise
por: Yuan, Weiming, et al.
Publicado: (2018)

Human brucellosis
por: Wiwanitkit, Viroj
Publicado: (2016)

A Review on Ophthalmic Manifestations of Brucellosis and Reporting a Case of Ophthalmic Brucellosis
por: Ghasemi Barghi, R, et al.
Publicado: (2011)

Brucellosis, Taiwan, 2011
por: Chuang, Yu-Chung, et al.
Publicado: (2011)

Brucellosis in Takins, China
por: Luo, Jing, et al.
Publicado: (2012)

Seropositivity for Brucellosis in Veterinarians
por: Patil, Niranjan B, et al.
Publicado: (2013)

Human brucellosis: An overview
por: Hasanjani Roushan, Mohammad Reza, et al.
Publicado: (2015)

Legionnaires' disease as an occupational risk related to decontamination work after the Fukushima nuclear disaster: A case report
por: Yoshida, Go J.
Publicado: (2018)

Live Nativity and Brucellosis, Sicily
por: Iaria, Chiara, et al.
Publicado: (2006)

Is Human Brucellosis Endemics in Korea?
por: Kim, Eun-Kyung, et al.
Publicado: (2017)

Brucellosis in Infant after Familial Outbreak
por: Makis, Alexandros C., et al.
Publicado: (2008)

Brucellosis Reactivation after 28 Years
por: Ögredici, Önder, et al.
Publicado: (2010)

Human Brucellosis, Inner Mongolia, China
por: Zhang, Wen-Yi, et al.
Publicado: (2010)

Ritual Slaughter as Overlooked Risk Factor for Brucellosis
por: Fuchs, Inbal, et al.
Publicado: (2016)

Molecular Diagnostic Methods of Brucellosis: a Note on Pitfalls
por: Hajia, Massoud, et al.
Publicado: (2018)

Spectrum of Occupational Injuries Presenting to the Emergency Department
por: Ragavi, A Indhu, et al.
Publicado: (2021)

Brucellosis Masquerading as Spondylodiscitis with Multiple Intervertebral Disc Prolapse
por: Andrabi, Syed Arshad Hussain, et al.
Publicado: (2012)

False-positivity in diagnosis of brucellosis associated with Rev-1 vaccine
por: Gunes, Hayati, et al.
Publicado: (2013)

Brucellosis in Guangdong Province, People’s Republic of China, 2005–2010
por: Chen, Jing-diao, et al.
Publicado: (2013)

First Case of Human Brucellosis Caused by Brucella melitensis in Korea
por: Kim, Hyeong Nyeon, et al.
Publicado: (2016)

Factors Associated With Public Trust in Pharmaceutical Manufacturers
por: Singh, Yashaswini, et al.
Publicado: (2023)

Acute Ischemic Stroke as a Presenting Feature of Brucellosis: A Case Report
por: Patel, Jalpan, et al.
Publicado: (2021)

Occupational Health Response to SARS
por: Koh, David, et al.
Publicado: (2005)

Danger of Potential-Pandemic-Pathogen Research Enterprises
por: Klotz, Lynn C.
Publicado: (2015)

Assessment of the Opportunities for Pharmaceutical Manufacturers in Emerging Markets
por: Anderson, Tim, et al.
Publicado: (2009)

Deep vein thrombosis associated with acute brucellosis: a case report and review of the literature
por: Koubaa, Makram, et al.
Publicado: (2013)

Mapping bovine Brucellosis in Colombia with geographical information systems, 2009–2019 – Implications for OneHealth
por: Bonilla-Aldana, D. Katterine, et al.
Publicado: (2023)

Granulomatous Spondylodiscitis as a Rare Manifestation of Brucellosis in a Patient on Maintenance Hemodialysis from India
por: Lingaraj, Umesha, et al.
Publicado: (2023)

The dynamics of coordination patterns in multiteam systems response to emergency: Case study from a pharmaceutical enterprise
por: Zhang, Ya-Wei, et al.
Publicado: (2022)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Keeping alive enterprises while embracing unprecedented COVID-19 restrictions
por: Soriano, Vicente, et al.
Publicado: (2020)

Environmental Compliance and Enterprise Innovation: Empirical Evidence from Chinese Manufacturing Enterprises
por: Liu, Meng, et al.
Publicado: (2021)

Continuous Pharmaceutical Manufacturing
por: Korhonen, Ossi
Publicado: (2020)

COVID-19 can delay the timely diagnosis of musculoskeletal brucellosis: A summary of evidence and recommendations for healthcare practitioners and health bodies
por: Tsagkaris, C., et al.
Publicado: (2022)

Beyond Stanton and Pott hypothesis; carbon nanotubes‐induced malignant mesothelioma as a disease of gene loss
por: Yoshida, Go J.
Publicado: (2019)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

A peculiar manufacturing defect in catheter mount
por: Bhanushali, Alpesh Chhaganlal, et al.
Publicado: (2016)

Standardization of Environmental Responsibility Behavior of Production and Manufacturing Enterprises in the Context of Green Economy
por: Chen, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c9hjrb4vukvgl74telip1ju9o